Created by Kathy Cochran

Diethylstilbestrol
(DES) is a synthetic estrogen, once promoted for use in the prevention of
miscarriages. The purpose of this website is to
examine a side effect of DES which the medical community and pharmaceutical
companies are reluctant to discuss. DES is now defined as an endocrine
disrupting chemical or EDC. Humanity has already learned several very
painful lessons form the great
DES experiment but
is this particular Pandora's box actually empty? The topic of this website
is extremely complex so please continue with an
open mind and be prepared to study as I present a substantial amount of
scientific data. Notably, the Gender Identity, Research and Lectures
pages.
In 1999, Dr. Scott Kerlin began
researching the effects of DES
on the health of genetic males who had been exposed prenatally. A
substantial amount of research had been done on genetic women who had been
exposed but relatively little had been done on genetic males. When it became apparent that a significant
portion of his research group were either transsexual, transgendered
or intersexed, he began to explore the possibility of a connection between prenatal
DES exposure and gender variance. Dr. Kerlin is not the first researcher to
note a
correlation between DES exposure and
feminized behavior in genetic males,
studies go back as far as
1973. However, Dr. Kerlin has delved much deeper than those who came before. (See the
timelines page of this site and the links and files section of the DES-Sons
group.)
|
KWMR radio interview with Dr. Scott Kerlin ( MP3, 5.2 MB
download ) |
|
KWMR radio interview with Dr. Dana Beyer ( MP3, 3.7 MB
download ) |
|
A new book by Deborah Rudacille, The Riddle of Gender: Science, Activism, and Transgender
Rights |
|
Dr. Beyer's and Deborah Rudacille's Interview with WAMU Radio The Science of Gender, (Starts at the 16 Minute point, requires Real Player)
|
|
Dr. Scott Kerlin, Prenatal Exposure to Diethylstilbestrol (DES)
in Males and Gender-Related Disorders,:Results from a 5-Year Study |
|
Publications by Christine Johnson,
MSEE, MES |
|
Gender Identity Research and Education Society,
Atypical Gender Development - A Review |
Because
DES is highly effective at reducing testosterone production, it was also used
in the treatment of prostate cancer. During prenatal development,
sufficient testosterone is essential
for the sexual differentiation of the brain. Male and female
brains are
structured slightly differently and yes, numerous animal studies
have proven that it's possible to influence the development of some
structures by manipulating the prenatal hormone balance of the
fetus. Animals with cross sexed brain structures also display cross sexed
behavior as adults. Is there a human equivalent? Gender dysphoria is the
medical term used to describe people who are born one sex but have the
feeling that they should have been born the opposite sex. For some of us
this feeling is so intense that we undergo gender reassignment surgery. The
common term for us is Transsexual.
Lets
begin with a quote from the well known
Merck Manual. The concept that prenatal hormone levels affect the sexual differentiation of the brain and are in part responsible for the development of our gender identity has become so well accepted that even the Merck manual states, "Although biologic factors, such as gender complement and the
prenatal hormonal milieu, largely determine gender identity, the formation of a secure,
unconflicted gender identity and gender role is influenced by social factors, such as the character of the parents' emotional bond and the relationship that each of them has with the child".
Merck is a major pharmaceutical company and
was one of the numerous manufacturers of DES.
In 1995, a group of researchers from the Netherlands published the following study. "A Sex Difference in the Human Brain and its Relation to Transsexuality". The report begins with the following paragraph. "Transsexuals have the strong feeling, often from childhood onwards, of having been born the wrong sex. The possible psychogenic or biological etiology of transsexuality has been the subject of debate for many years. Here we show that the volume of the central subdivision of the bed nucleus of the stria terminalis (BSTc), a brain area that is essential for sexual behaviour, is larger in men than in women. A female-sized BSTc was found in male-to-female transsexuals. The size of the BSTc was not influenced by sex hormones in adulthood and was independent of sexual orientation. Our study is the first to show a female brain structure in genetically male transsexuals and supports the hypothesis that
gender identity develops as a result of an interaction between the developing brain and sex hormones".
Some people have
argued that the changes in brain structure noted in the above paper may have
been caused by
exposure to hormones as an adult. In 2000,
researchers examined the brains of people who, for a variety of
reasons had been exposed to similar hormone regimes as transsexual people
regularly take and did not find the brain structure in question to be
affected. Males had a typical male brain structure and females had a typical
female brain structure. Others have argued that the sample of brains studied
is to small. One should keep in mind that although the human sample is
small, studies on other mammals is extensive. In fact, DES is now used as a
positive control when researching the effects of other endocrine
disrupting chemicals. For instance,.
"Sex
difference eliminated (males behave like control females)"
Since then, many of the worlds top researchers
who study gender identity have signed a document titled "Definition and Synopsis of the Etiology of Adult Gender Identity Disorder and Transsexualism". This document states that "Transsexualism can be considered to be a neuro-developmental condition of the brain". It also states the
following. "Factors which may contribute to an altered hormone environment in the brain at the critical moments in its early development might include genetic influences (Landen, 1999; Coolidge et al, 2002) and/or medication, environmental influences (Diamond et al., 1996; Whitten et al., 2002), stress or trauma to the mother during pregnancy (Ward et al., 2002; Swaab et al., 2002)". Please note the word medication in the above quote.
The comment about
genetic influences is also apt because in addition to existing data, in 2005 a paper titled "Sex
steroid-related genes and male-to-female transsexualism" was
published, and discussed the genetic coding of the hormone receptors of 29
transsexual people. As it turns out they exhibited a genetic variation which
is quite common amongst many people but may make them more susceptible to
certain types of endocrine disruption.
Lets look at a few
more quotes. "Gender
Benders & Endocrine Disruptors around You".
"Abnormal
development of gender-specific sexual behavior in DES offspring (feminized
males and masculinized females), suggesting that DES caused abnormal sex
differentiation during fetal development " and "Abnormal
development of male sexual behavior "
(Elizabeth
Lee Vliet, MD quotes an excerpt from "Its My Ovaries, Stupid, pgs. 83 107
Scribner, 2003 " )
This is from
the chemical reference standard, Dictionary
of Organic Compounds, 6th Edition (1996). In reference to
diethylstilbestrol, it includes the following under its stated adverse
human health effects. "Causes male impotence and transsexual changes particularly in offspring exposed in utero".
Can't get much more direct than that.
I've contacted numerous neuroscientists around the globe.
Most were kind enough to respond and of those who did, none were
surprised.
Here is
one of numerous quotes from University Professors found on the lectures page
of this website.
Geert J.
De Vries
Hormonal Control of Sexual Differentiation
"Gonadal hormones profoundly influence brain
physiology and behavior in vertebrates. During development, these hormones
determine whether brains will function in a typical male or female fashion."
The above quotes are just the tip of the iceberg, a summary of a very
complex issue. The subsequent pages of this website provide much more
information.
One obvious question is, what do the pharmaceutical companies
have to say about this issue? From my own personal experience
the answer is in essence "no comment". I've sent them the
link to this website and although I know they have visited it,
(I can see the Domain Name of those who visit) not once have I
ever received a reply or comment.
How about our governments and Health Care providers? The
responses I've received from Health Canada are very polite and
oh so carefully worded. I've never received a response from the
Centers for Disease
Control. However, displayed on the CDC website is a portion
of a paper titled
Psychosexual Characteristics of Men and Women Exposed Prenatally
to Diethylstilbestrol Unfortunately the researchers
who published this paper somehow forgot to include transgendered/transsexual
people in their study. Despite my prodding, the CDC hasn't been
inclined to post a link to the
complete paper, I wonder why?
Could it be this? Embedded in the rest of the paper is the
following statement: "Briefly, 1% of the
poten-tially eligible women (exposed or unexposed) and 3% of the
men (5% exposed, 2% unexposed) had died before the combined
study was implemented ". This paper, which the CDC holds
in such high regard, is reporting that the mortality rate of DES
exposed males is 2.5 times higher than the control group.